Graves' ophthalmopathy and atrophic thyroiditis: A case report

被引:1
作者
Tamagno, G
De Carlo, E
Betterle, C
Murialdo, G
机构
[1] Univ Genoa, Dipartimento Sci Endocrinol & Metab, I-16132 Genoa, Italy
[2] Univ Padua, Dept Med & Surg Sci, Padua, Italy
关键词
Graves' ophthalmopathy; thyroid autoimmune disease; TSH-receptor antibodies; atrophic thyroiditis;
D O I
10.1007/BF03346262
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graves' ophthalmopathy (GO) - also known as thyroid-associated orbitopathy or ophthalmopathy - usually affects patients with Graves' disease. Antibodies stimulating the TSH receptor are thought to be involved in the pathogenesis of this important and disabling extra-thyroidal manifestation of Graves' disease. Less frequently, GO occurs in subjects who neither have nor have ever shown evidence of thyroid dysfunction ("euthyroid GO"), while the occurrence of GO in patients with autoimmune Hashimoto's thyroiditis is thought to be quite rare and has sporadically been reported. The late and abrupt occurrence of severe GO without hyperthyroidism in an 88-yr-old woman with primary myxedema due to atrophic thyroiditis must be considered as an exceptional event. In this patient, GO was combined with elevated titres of serum auto-antibodies directed against the TSH receptor, while serum levels of anti-thyroglobulin and thyroperoxidase antibodies were within the normal range or only occasionally slightly above the normal values. (C) 2004, Editrice Kurtis.
引用
收藏
页码:163 / 166
页数:4
相关论文
共 28 条
  • [1] Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: Potential autoantigen in Graves' ophthalmopathy
    Bahn, RS
    Dutton, CM
    Natt, N
    Joba, W
    Spitzweg, C
    Heufelder, AE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (03) : 998 - 1002
  • [2] The genetics of Hashimoto's disease
    Barbesino, G
    Chiovato, L
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2000, 29 (02) : 357 - +
  • [3] Management of Graves' ophthalmopathy: Reality and perspectives
    Bartalena, L
    Pinchera, A
    Marcocci, C
    [J]. ENDOCRINE REVIEWS, 2000, 21 (02) : 168 - 199
  • [4] Management of thyroid eye disease
    Bartalena, L
    Marcocci, C
    Tanda, ML
    Pinchera, A
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (Suppl 2) : S458 - S465
  • [5] GRAVES HYPERTHYROIDISM FOLLOWING PRIMARY HYPOTHYROIDISM - SEQUENTIAL-CHANGES IN VARIOUS ACTIVITIES OF THYROTROPIN RECEPTOR ANTIBODIES
    CHO, BY
    SHONG, YK
    LEE, HK
    KOH, CS
    MIN, HK
    [J]. ACTA ENDOCRINOLOGICA, 1989, 120 (04): : 447 - 450
  • [6] HIGH PREVALENCE AND LITTLE CHANGE IN TSH RECEPTOR BLOCKING ANTIBODY-TITERS WITH THYROXINE AND ANTITHYROID DRUG-THERAPY IN PATIENTS WITH NON-GOITROUS AUTOIMMUNE-THYROIDITIS
    CHO, BY
    KIM, WB
    CHUNG, JH
    YI, KH
    SHONG, YK
    LEE, HK
    KOH, CS
    [J]. CLINICAL ENDOCRINOLOGY, 1995, 43 (04) : 465 - 471
  • [7] CHRISTY JH, 1972, AM J MED, V2, P291
  • [8] Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment
    Dickinson, AJ
    Perros, P
    [J]. CLINICAL ENDOCRINOLOGY, 2001, 55 (03) : 283 - 303
  • [9] DUCORNET B, 1995, ANN MED INTERNE PARI, V146, P558
  • [10] Severe thyroid eye disease associated with primary hypothyroidism and thyroid-associated dermopathy
    Gleeson, H
    Kelly, W
    Toft, A
    Dickinson, J
    Kendall-Taylor, P
    Fleck, B
    Perros, P
    [J]. THYROID, 1999, 9 (11) : 1115 - 1118